| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 16 |
| 1 | VANCOMYCIN | 14 |
| 2 | ANIDULAFUNGIN | 13 |
| 3 | DAPTOMYCIN | 13 |
| 4 | FLUCONAZOLE | 13 |
| 5 | LINEZOLID | 13 |
| 6 | MEROPENEM | 13 |
| 7 | CASPOFUNGIN ACETATE | 10 |
| 8 | BISOPROLOL FUMARATE | 7 |
| 9 | HYDROXYCHLOROQUINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANIDULAFUNGIN | 13 | 0.0080 |
| 1 | CASPOFUNGIN ACETATE | 10 | 0.0063 |
| 2 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 3 | DAPTOMYCIN | 13 | 0.0014 |
| 4 | LINEZOLID | 13 | 0.0004 |
| 5 | MEROPENEM | 13 | 0.0004 |
| 6 | VANCOMYCIN | 14 | 0.0002 |
| 7 | COBIMETINIB | 1 | 0.0002 |
| 8 | FLUCONAZOLE | 13 | 0.0002 |
| 9 | BEVACIZUMAB | 16 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 17 |
| 1 | Glycopeptide Antibacterial [EPC] | 14 |
| 2 | Azole Antifungal [EPC] | 13 |
| 3 | Echinocandin Antifungal [EPC] | 13 |
| 4 | Lipopeptide Antibacterial [EPC] | 13 |
| 5 | Oxazolidinone Antibacterial [EPC] | 13 |
| 6 | Penem Antibacterial [EPC] | 13 |
| 7 | Platinum-based Drug [EPC] | 8 |
| 8 | Corticosteroid [EPC] | 7 |
| 9 | Factor Xa Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 13 | 0.0016 |
| 1 | Lipopeptide Antibacterial [EPC] | 13 | 0.0014 |
| 2 | Oxazolidinone Antibacterial [EPC] | 13 | 0.0004 |
| 3 | Penem Antibacterial [EPC] | 13 | 0.0004 |
| 4 | Glycopeptide Antibacterial [EPC] | 14 | 0.0002 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 17 | 0.0001 |
| 7 | Azole Antifungal [EPC] | 13 | 0.0001 |
| 8 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 9 | Thiazide-like Diuretic [EPC] | 2 | 0.0000 |